Trial
NCT05101356
A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma
Phase ISUSPENDEDSAFETYConfidence: HIGH
Sponsor
University of California, Davis
Collaborators
National Cancer Institute (NCI); LabyRx Immunologic Therapeutics
Condition
Advanced Adenocarcinoma
Intervention
Antineoplastic Vaccine
Why stopped
Drugs unavailable
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-29